CLAFORAN - PWS INJ 500MG/VIAL
CLAFORAN - PWS INJ 500MG/VIAL
Discontinued
DIN Number
02225085
Drug Class
Human
Market Date
Dec 19, 2003
Company
HC
sanofi-aventis canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02225085
AIG Number0152507003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J01DD01 CEFOTAXIME
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntramuscular
,
Intravenous
AHFS Classification08:12.06.12
Health Canada Classification
ACTIVE INGREDIENTS (1)
CEFOTAXIME SODIUMActive
Strength: 500 MG / VIAL
Monograph: CEFOTAXIME SODIUM